340B drug purchases hit at least $100B in 2025, administrator reports

Outpatient drug purchases under the 340B Drug Pricing Program crossed the $100 billion mark across 2025, a roughly 23% increase over the $81.4 billion of 2024, the Health Resources & Services A | The tally reflects a 23% increase over 2024, another substantial escalation in scale for the subsidy program critics say is being abused by large nonprofit hospitals.